<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-38287" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part indexed="no" book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Risk Stratification, Cardiac (Archived)</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Singh</surname>
            <given-names>Shashank</given-names>
          </name>
          <aff>Louisiana State Un Health Science Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Zeltser</surname>
            <given-names>Roman</given-names>
          </name>
          <aff>Hofstra Northwell School of Medicine</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Shashank Singh declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Roman Zeltser declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>8</day>
          <month>2</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-38287.s1" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Cardiac risk stratification is a very broad topic but simply&#x000a0;can be defined as an assessment used to evaluate a patient's risk of developing cardiovascular disease (CVD) or the risk of a cardiac event occurring in noncardiac surgeries, also known as a perioperative risk assessment. This article will discuss both the risk assessment for CVD and the risk assessment in the perioperative setting.</p>
      </sec>
      <sec id="article-38287.s2" sec-type="Function">
        <title>Function</title>
        <p><bold>Cardiovascular Disease Assessment</bold>Cardiovascular disease is categorized into four groups: coronary heart disease, cerebrovascular disease, peripheral artery disease, aortic atherosclerosis, and thoracic or abdominal aortic aneurysms. Several established risk factors can be further categorized into nonmodifiable and adjustable ones. The importance of understanding the significance of risk assessment lies in the epidemiology of CVD. Cardiovascular disease is the number 1 cause of death globally and is projected to remain the world&#x02019;s major disease burden, accounting for more than 23.6 million deaths per year by 2030.<xref ref-type="bibr" rid="article-38287.r1">[1]</xref>&#x000a0;It is a source of significant morbidity and mortality as well as a large portion of economic loss, especially in low- to middle-income countries, as reported by the World Health Organization.<xref ref-type="bibr" rid="article-38287.r1">[1]</xref>&#x000a0;Reducing the incidence by primary prevention will play a significant role; however, it is important to understand that medical therapy is only part of the overall solution. Adequate risk reduction through education will be paramount in risk reduction.</p>
        <p>
<bold>Cardiovascular Risk Factors</bold>
</p>
        <p>Risk factors for cardiovascular disease can be separated into nonmodifiable and modifiable risk factors. These risk factors have been shown to have a cumulative effect over time in that the progression of CVD&#x000a0;is related to the number of risk factors present and their persistence over time. More simply,&#x000a0;the risk of developing CVD increases with the number of risk factors acquired and the time they have been present.<xref ref-type="bibr" rid="article-38287.r2">[2]</xref></p>
        <p>Nonmodifiable risk factors are age, gender, and family history. Specifically, these risk factors are permanent, and very little can be done to decrease an established risk from these factors. Several studies have shown that the prevalence of CVD increases with age, where each decade of life above the age of 40 showed a significant increase in the prevalence of any vascular disease.<xref ref-type="bibr" rid="article-38287.r3">[3]</xref>&#x000a0;The male gender has been shown to have a baseline increased risk than females across several populations.<xref ref-type="bibr" rid="article-38287.r4">[4]</xref>&#x000a0;Family history has been shown across multiple studies to be an independent risk factor for the development of CVD or future myocardial infarction, specifically parental family history.<xref ref-type="bibr" rid="article-38287.r5">[5]</xref><xref ref-type="bibr" rid="article-38287.r6">[6]</xref>&#x000a0;A positive family history of CVD is described as any 1st-degree relative who has undergone death or development of CVD before the age of 55 for males or 65 for females.</p>
        <p>The remaining risk factors are modifiable and can be further categorized into health conditions and lifestyle factors. Health conditions include hypertension, dyslipidemia, diabetes mellitus, and chronic kidney disease (CKD). Lifestyle factors include cigarette smoking, diet and exercise, obesity, and psychosocial factors. Hypertension has an abundant amount of evidence to support its role as a risk factor in developing CVD. A meta-analysis published in 2002 shows that blood pressure is &#x0201c;strongly and directly related to vascular (and overall) mortality,&#x0201d; showing that a difference of 20 mmHg of systolic or 10 mm Hg of diastolic pressure is associated with a nearly twofold difference in cardiovascular disease death rate.<xref ref-type="bibr" rid="article-38287.r7">[7]</xref>&#x000a0;Dyslipidemia, defined as elevated total or LDL cholesterol, low HDL cholesterol, and disturbances in lipoprotein metabolism, has been independently associated with CVD.<xref ref-type="bibr" rid="article-38287.r8">[8]</xref><xref ref-type="bibr" rid="article-38287.r9">[9]</xref>&#x000a0;Diabetes mellitus is considered a coronary heart disease (CHD) equivalent<xref ref-type="bibr" rid="article-38287.r10">[10]</xref> secondary to the finding that patients with diabetes only had a similar risk of myocardial infarction compared to those without diabetes but with a prior myocardial infarction.<xref ref-type="bibr" rid="article-38287.r11">[11]</xref>&#x000a0;Chronic kidney disease is now also considered a CHD equivalent, just as diabetes mellitus is. Secondary to both proteinuria and a decreased glomerular filtration rate, it was shown that patients with even moderate renal impairment based on GFR and increased proteinuria were associated with an increase in all-cause and cardiovascular mortality compared to those with normal renal function.<xref ref-type="bibr" rid="article-38287.r12">[12]</xref>&#x000a0;Cigarette smoking is associated with a higher risk of myocardial infarction and is related to the amount used; however, the benefits of cessation are significant regardless of the amount or length of use. One study showed that smokers who stopped smoking had a risk similar to that of a nonsmoker within two years of quitting in a population of patients who had suffered a prior myocardial infarction.<xref ref-type="bibr" rid="article-38287.r13">[13]</xref>&#x000a0;Diets high in red meat and high-fat dairy products have been associated with having a higher risk of CHD.<xref ref-type="bibr" rid="article-38287.r14">[14]</xref>&#x000a0;A risk reduction was shown with diets high in fiber and daily consumption of fruits and vegetables. Exercise has been shown to reduce CHD risk and overall cardiovascular mortality. Obesity was shown to have a direct relationship with CVD risk.<xref ref-type="bibr" rid="article-38287.r15">[15]</xref></p>
        <p>
<bold>Cardiovascular Risk Assessment and Reduction</bold>
</p>
        <p>Cardiovascular risk can be assessed through several different risk models accounting for separate risk factors, some overlapping with other risk models. No single risk model is the supreme choice, although the ACC/AHA published guidelines in 2013 recommending the use of the ACC/AHA pooled cohort hard CVD risk score in the United States. Regardless of the chosen risk model, patients are categorized in a low, intermediate, and high estimated 10-year risk for developing CVD. Based on the patient&#x02019;s category, further therapy for primary prevention can be warranted, or lifestyle&#x000a0;changes and reassessment can be done. Primary medical prophylaxis usually involves aspirin or statin initiation but can involve medical therapy to reduce other risk factors, e.g., smoking cessation, depression, hypertensive medication, etc.</p>
        <p>
<bold>Perioperative Risk Assessment</bold>
</p>
        <p>Perioperative risk assessment is used to evaluate a patient&#x02019;s risk of perioperative cardiac morbidity and mortality in noncardiac surgeries. It helps facilitate a patient's informed decision by providing a risk/benefit illustration of the surgical intervention. Any patient planned for a noncardiac surgery should be risk-stratified as it forces clinicians to perform a thorough evaluation.<xref ref-type="bibr" rid="article-38287.r16">[16]</xref><xref ref-type="bibr" rid="article-38287.r17">[17]</xref>&#x000a0;Devereaux reports an estimated 1.4 to 3.9% of surgical procedures are complicated by major cardiac events.<xref ref-type="bibr" rid="article-38287.r18">[18]</xref>&#x000a0;The assessment is patient and surgery-specific, considering independent risk predictors. Several risk assessment tools are available. However, all consider the patient's clinical history and physical regarding independent clinical markers, including their functional capacity and the type of&#x000a0;surgery to be performed. Considering these important parameters leads the clinician and patient to decide to either proceed with elective surgery or explore other therapies and defer surgical intervention.</p>
        <p>
<bold>Perioperative Risk Clinical Markers</bold>
</p>
        <p>The independent clinical markers used in large studies as risk predictors are coronary artery disease (CAD), prior heart failure, diabetes, and renal failure. Each of these predictors carries a relative risk of approximately 2.0 to 5.0 <xref ref-type="bibr" rid="article-38287.r19">[19]</xref>&#x000a0;for major cardiac complications.</p>
        <p>Diagnosed&#x000a0;coronary artery disease (CAD)&#x000a0;carries a relative risk of 2.9 for major cardiac complications in the perioperative setting.<xref ref-type="bibr" rid="article-38287.r19">[19]</xref>&#x000a0;It is estimated that about 6.2% of the US adult population is affected by&#x000a0;CAD&#x000a0;<xref ref-type="bibr" rid="article-38287.r20">[20]</xref>, and occasionally, patients without any known history of CAD are diagnosed during preoperative evaluation only with an electrocardiogram (ECG) showing an old infarction. It is essential to distinguish that known CAD is separate from active/recent acute coronary syndrome, with the latter carrying a higher risk of perioperative morbidity and mortality and the postoperative incidence of major cardiac complications.<xref ref-type="bibr" rid="article-38287.r21">[21]</xref>&#x000a0;Prior heart failure has a relative risk of 2.1 for major cardiac complications in the perioperative setting <xref ref-type="bibr" rid="article-38287.r19">[19]</xref>,&#x000a0;with acutely decompensated heart failure carrying an even higher risk. Diabetes mellitus with perioperative insulin use and established CAD equivalent carries a relative risk of 3.5 for major cardiac complications.<xref ref-type="bibr" rid="article-38287.r19">[19]</xref>&#x000a0;Chronic renal failure with perioperative serum creatinine greater than 2.0 mg/dL has a relative risk of 5.2 for a major cardiac event.<xref ref-type="bibr" rid="article-38287.r19">[19]</xref></p>
        <p>Functional capacity is quantified and characterized by metabolic equivalents (METs), where "excellent" is greater than 10 METs, "good" is 7 to 10 METs, "moderate" is 4 to 6 METs, and poor is less than 4 METs.<xref ref-type="bibr" rid="article-38287.r21">[21]</xref>&#x000a0;Patients with poor functional capacity have a relative risk of 1.8 for major cardiac complications.<xref ref-type="bibr" rid="article-38287.r19">[19]</xref></p>
        <p>Different types of&#x000a0;surgeries carry separate risks. A low-risk procedure is where the combined surgical and patient characteristics predict the risk of cardiac complications less than 1%. In contrast, a high-risk procedure predicts a risk greater than 1%. Generally, high-risk surgeries include any intraperitoneal, intrathoracic, or suprainguinal vascular procedure carrying a relative risk of 2.1 for major cardiac complications.<xref ref-type="bibr" rid="article-38287.r19">[19]</xref>&#x000a0;Low-risk surgeries include endoscopic intervention, ophthalmologic procedures, minimally invasive procedures, superficial procedures, and electroconvulsive therapy. All other procedures fall under intermediate risk.</p>
        <p>Additional conditions that should warrant evaluation and consideration are any severe symptomatic valvular disease, known pulmonary vascular disease, or any unexplained dyspnea. Both conditions cause a significant increase in the risk of perioperative major cardiac complications.<xref ref-type="bibr" rid="article-38287.r22">[22]</xref><xref ref-type="bibr" rid="article-38287.r23">[23]</xref></p>
        <p>All these predictors of risk are used to calculate a patient&#x02019;s percentage of major cardiac complications. Several risk calculators, such as the Revised Cardiac Risk Index (RCRI) or National Surgical Quality Improvement Program, help establish a baseline clinical risk to dictate further whether perioperative testing is necessary. Most commonly, RCRI is used to calculate the risk of a major cardiac complication. This tool was based on the works of Goldman et al. in 1977 and first published in 1999 by Lee et al. using the following six clinical markers, the risk&#x000a0;is calculated:</p>
        <list list-type="order">
          <list-item>
            <p>History of ischemic&#x000a0;heart disease</p>
          </list-item>
          <list-item>
            <p>History of congestive heart failure</p>
          </list-item>
          <list-item>
            <p>History of cerebrovascular disease (including transient ischemic attacks)</p>
          </list-item>
          <list-item>
            <p>History of diabetes requiring preoperative insulin use</p>
          </list-item>
          <list-item>
            <p>Chronic kidney disease with creatinine greater than 2 mg/dL</p>
          </list-item>
          <list-item>
            <p>A planned procedure that&#x000a0;is, by definition, a high-risk surgery</p>
          </list-item>
        </list>
        <p>Each parameter is given a point, and the patient is given a risk of primary cardiac complications based on a relative RCRI score of 0 to 6. The rates of major cardiac complications with 0, 1, 2, or greater than or equal to 3 clinical markers were 0.4%, 0.9%, 6.6%, and 11% respectively.</p>
        <p>Furthermore, the differences between emergency, urgent, and elective surgeries should be defined, as emergency surgery does not allow for and require a preoperative assessment, unlike urgent and elective surgeries. Emergency surgery is defined as a procedure in which life or limb is threatened if the patient is not taken to the operating room in less than 6 hours. This contrasts urgent surgery, where life or limb is threatened if not in the operating room within 6 to 24 hours. Elective surgery is any procedure that can be delayed&#x000a0;safely&#x000a0;for up to 1 year.</p>
        <p>
<bold>Perioperative Cardiac Testing</bold>
</p>
        <p>Who should be tested? Simply, the answer depends on whether the results change management. In 2014, the American College of Cardiology published a stepwise algorithm for assessment regarding perioperative testing.<xref ref-type="bibr" rid="article-38287.r16">[16]</xref>&#x000a0;Any patient who needs immediate surgery does not undergo preoperative cardiac testing. All other urgent and elective procedures require the following conditions to be treated and managed before proceeding to surgery: ACS, decompensated heart failure, significant arrhythmias, and severe valvular disease. If none are present, patients whose risk of primary cardiac complications is greater than 1% with poor or unknown functional capacity should be considered for testing. Obtaining a preoperative electrocardiogram is reasonable in patients with known CAD or those who are undergoing moderate to high-risk surgery.<xref ref-type="bibr" rid="article-38287.r16">[16]</xref>&#x000a0;Cardiac stress testing was shown only to be beneficial for patients who are neither low nor high risk by clinical assessment as the results can re-classify these moderate-risk patients into low and high categories based on results <xref ref-type="bibr" rid="article-38287.r24">[24]</xref>, which may help the clinician and patient reconsider intervention. The etiology of perioperative cardiovascular events has been reported to be secondary to catecholamine surges leading to coronary artery shear stress and increased oxygen demand, coronary artery atherosclerotic disease, hypoxic state, prothrombotic events, and a generalized inflammatory state.<xref ref-type="bibr" rid="article-38287.r18">[18]</xref>&#x000a0;Of these causes, cardiac stress testing, especially in the perioperative setting, only tests for significant CAD but is not able to elaborate on the other etiologies.</p>
        <p>Prophylactic&#x000a0;percutaneous coronary intervention was once done for patients with stable CAD undergoing elective vascular surgery with the thought that&#x000a0;these patients have a significant hospital and 30-day cardiac mortality rate.<xref ref-type="bibr" rid="article-38287.r25">[25]</xref>&#x000a0;This was tested in the coronary artery revascularization prophylaxis (CARP) trial, resulting in no mortality benefit by performing coronary artery revascularization before elective vascular surgery, extrapolating that stable CAD should be medically managed in the setting of elective noncardiac surgery.<xref ref-type="bibr" rid="article-38287.r26">[26]</xref></p>
        <p>
<bold>Perioperative Management</bold>
</p>
        <p>Perioperative medical management has had several criticisms, especially surrounding the use of beta-blockers and statins in the perioperative setting. The controversy surrounding DECREASE trials and subsequent results of the Perioperative Ischemic Evaluation (POISE) trial brought into question beta-blockers' role in the perioperative setting.</p>
        <p>Beta-blockers were initially shown to reduce mortality and incidence of cardiovascular complications for up to 2 years after surgery in a 1996 study.<xref ref-type="bibr" rid="article-38287.r27">[27]</xref>&#x000a0;This was again shown in 1999 by Podermans with astounding results. This trial tested the use of bisoprolol in the setting of elective aortic surgery, resulting in an absolute risk reduction from a standard risk of 35% to 3.5% risk in the beta-blocker group.<xref ref-type="bibr" rid="article-38287.r28">[28]</xref>&#x000a0;The subsequent POISE trial was conducted to evaluate further and solidify the findings regarding the benefit of the beta-blockers. This trial had two findings: the primary endpoint showed a statistical benefit with the use of beta-blockers, with a reduction in the risk of myocardial infarction, cardiac revascularization, and clinically significant atrial fibrillation 30 days after randomization compared to placebo.<xref ref-type="bibr" rid="article-38287.r29">[29]</xref>&#x000a0;However, the secondary endpoint showed a significant excess in the risk of death, stroke, and clinically significant hypotension and bradycardia.<xref ref-type="bibr" rid="article-38287.r29">[29]</xref>&#x000a0;Conflicting endpoints, but both are statistically significant. This study showed that beta-blockers given in high doses on the day of surgery have a risk. Thus, guideline therapy now states that patients who&#x000a0;are already on beta-blockers should continue them; patients who are at moderate to high risk of major cardiac complications are reasonable to start before the day of surgery. However, beta-blockers should not be started on the day of surgery. This is a class-III recommendation.<xref ref-type="bibr" rid="article-38287.r16">[16]</xref><xref ref-type="bibr" rid="article-38287.r21">[21]</xref></p>
        <p>Statin therapy was also under criticism; however, far less than beta-blockers. This was secondary to, again, DECREASE III and IV trials, reporting an exaggerated benefit of statin therapy and combined beta-blocker/statin therapy, respectively.<xref ref-type="bibr" rid="article-38287.r30">[30]</xref><xref ref-type="bibr" rid="article-38287.r31">[31]</xref>&#x000a0;Unfortunately, the results of most of the DECREASE trials were found to be fictitiously reported, and guidelines based on their findings were&#x000a0;retracted.<xref ref-type="bibr" rid="article-38287.r32">[32]</xref>&#x000a0;Regardless, other trials have shown benefit in lowering the risk of major cardiac complications in the perioperative vascular surgery and with patients with known CAD in the perioperative setting, although not as high as the DECREASE III and IV trials.<xref ref-type="bibr" rid="article-38287.r33">[33]</xref><xref ref-type="bibr" rid="article-38287.r34">[34]</xref><xref ref-type="bibr" rid="article-38287.r33">[33]</xref>&#x000a0;Guideline therapy suggests continuing statin on patients already on statins; initiation of statin is reasonable in patients undergoing vascular disease.<xref ref-type="bibr" rid="article-38287.r16">[16]</xref></p>
        <p>Alpha agonists (for example, clonidine) have no benefit in the perioperative setting to reduce major cardiac complications&#x000a0;<xref ref-type="bibr" rid="article-38287.r35">[35]</xref>&#x000a0;and&#x000a0;are not recommended for perioperative use.<xref ref-type="bibr" rid="article-38287.r16">[16]</xref>&#x000a0;The use of angiotensin-converting enzyme inhibitors (ACEI) is reasonable to continue if the patient is already on ACEI. However, there is no significant difference in reducing major cardiac complications.<xref ref-type="bibr" rid="article-38287.r21">[21]</xref></p>
        <p>Anticoagulants must be determined considering the clinical history and the surgical procedure to be done. Surgical procedures with a low risk of bleeding may have anticoagulation continued. For patients with a high risk of thromboembolic disease (for example, patients with mechanical valves), it may be reasonable to continue anticoagulation if there is a low risk of bleeding. In general, therapeutic anticoagulants are discouraged because of their harmful effect on the ability to control and contain surgical blood loss&#x000a0;<xref ref-type="bibr" rid="article-38287.r16">[16]</xref>.</p>
        <p>The role of antiplatelet agents is focused on patients already on long-term antiplatelet therapy, usually in the context of&#x000a0;prior cardiac stent placement. However, one study showed that even in patients with an elevated operative risk, aspirin in the perioperative setting does not reduce the rate of all-cause mortality or non-fatal myocardial infarction and&#x000a0;is associated with an increased risk of significant bleeding.<xref ref-type="bibr" rid="article-38287.r36">[36]</xref>&#x000a0; It is a class-III recommendation that the initiation or continuation of aspirin is not beneficial in patients undergoing elective noncardiac surgery who have not had previous coronary stenting unless the risk of ischemic events outweighs the risk of surgical bleeding. It is a class-I recommendation for patients undergoing urgent surgery during the first 4 to 6 weeks after cardiac stent placement, dual antiplatelet therapy (DAPT) should be continued unless the relative risk of bleeding outweighs the benefit of preventing stent thrombosis. In patients with cardiac stents, if the surgical procedure requires discontinuation of DAPT, these patients should be continued on aspirin, and complete DAPT should be restarted as soon as possible.<xref ref-type="bibr" rid="article-38287.r16">[16]</xref></p>
      </sec>
      <sec id="article-38287.s3" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>Cardiac risk stratification is an instrumental assessment and very&#x000a0;patient-specific regarding the decision to proceed to surgery. It is an assessment requiring the entire healthcare team to provide the best care to our patients. Evidence-based guideline therapy is not all-inclusive but has brought us closer to delivering prediction and expectation in the perioperative setting. As continued research is performed, advancements in testing, improved patient care, and cost-effectiveness will bring us closer to risk reduction and making the best decision in the perioperative setting.</p>
      </sec>
      <sec id="article-38287.s4" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>When the nurse practitioner, internist, and primary care provider have cardiac patients who need elective surgery, it is vital to get them cleared by a cardiologist. Cardiac risk stratification is an instrumental assessment and very&#x000a0;patient-specific regarding the decision to proceed to surgery. It is an assessment requiring the entire interprofessional team to provide the best care to our patients. Evidence-based guideline therapy is not all-inclusive but has brought us closer to delivering prediction and expectation in the perioperative setting. As continued research is performed, advancements in testing, improved patient care, and cost-effectiveness will bring us closer to risk reduction and making the best decision in the perioperative setting.</p>
      </sec>
      <sec id="article-38287.s5">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=38287&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=38287">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/38287/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=38287">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-38287.s6">
        <title>References</title>
        <ref id="article-38287.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Laslett</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>Alagona</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Clark</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Drozda</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Saldivar</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Wilson</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Poe</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Hart</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>The worldwide environment of cardiovascular disease: prevalence, diagnosis, therapy, and policy issues: a report from the American College of Cardiology.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2012</year>
            <month>Dec</month>
            <day>25</day>
            <volume>60</volume>
            <issue>25 Suppl</issue>
            <fpage>S1</fpage>
            <page-range>S1-49</page-range>
            <pub-id pub-id-type="pmid">23257320</pub-id>
          </element-citation>
        </ref>
        <ref id="article-38287.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jackson</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Lawes</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Bennett</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Milne</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Rodgers</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Treatment with drugs to lower blood pressure and blood cholesterol based on an individual's absolute cardiovascular risk.</article-title>
            <source>Lancet</source>
            <string-date>2005 Jan 29-Feb 4</string-date>
            <volume>365</volume>
            <issue>9457</issue>
            <fpage>434</fpage>
            <page-range>434-41</page-range>
            <pub-id pub-id-type="pmid">15680460</pub-id>
          </element-citation>
        </ref>
        <ref id="article-38287.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Savji</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Rockman</surname>
                <given-names>CB</given-names>
              </name>
              <name>
                <surname>Skolnick</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>Guo</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Adelman</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Riles</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Berger</surname>
                <given-names>JS</given-names>
              </name>
            </person-group>
            <article-title>Association between advanced age and vascular disease in different arterial territories: a population database of over 3.6 million subjects.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2013</year>
            <month>Apr</month>
            <day>23</day>
            <volume>61</volume>
            <issue>16</issue>
            <fpage>1736</fpage>
            <page-range>1736-43</page-range>
            <pub-id pub-id-type="pmid">23500290</pub-id>
          </element-citation>
        </ref>
        <ref id="article-38287.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kappert</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>B&#x000f6;hm</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Schmieder</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Schumacher</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Teo</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Yusuf</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sleight</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Unger</surname>
                <given-names>T</given-names>
              </name>
              <collab>ONTARGET/TRANSCEND Investigators</collab>
            </person-group>
            <article-title>Impact of sex on cardiovascular outcome in patients at high cardiovascular risk: analysis of the Telmisartan Randomized Assessment Study in ACE-Intolerant Subjects With Cardiovascular Disease (TRANSCEND) and the Ongoing Telmisartan Alone and in Combination With Ramipril Global End Point Trial (ONTARGET).</article-title>
            <source>Circulation</source>
            <year>2012</year>
            <month>Aug</month>
            <day>21</day>
            <volume>126</volume>
            <issue>8</issue>
            <fpage>934</fpage>
            <page-range>934-41</page-range>
            <pub-id pub-id-type="pmid">22829023</pub-id>
          </element-citation>
        </ref>
        <ref id="article-38287.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sesso</surname>
                <given-names>HD</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>IM</given-names>
              </name>
              <name>
                <surname>Gaziano</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Rexrode</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Glynn</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Buring</surname>
                <given-names>JE</given-names>
              </name>
            </person-group>
            <article-title>Maternal and paternal history of myocardial infarction and risk of cardiovascular disease in men and women.</article-title>
            <source>Circulation</source>
            <year>2001</year>
            <month>Jul</month>
            <day>24</day>
            <volume>104</volume>
            <issue>4</issue>
            <fpage>393</fpage>
            <page-range>393-8</page-range>
            <pub-id pub-id-type="pmid">11468199</pub-id>
          </element-citation>
        </ref>
        <ref id="article-38287.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Roncaglioni</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Santoro</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>D'Avanzo</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Negri</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Nobili</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ledda</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Pietropaolo</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Franzosi</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>La Vecchia</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Feruglio</surname>
                <given-names>GA</given-names>
              </name>
            </person-group>
            <article-title>Role of family history in patients with myocardial infarction. An Italian case-control study. GISSI-EFRIM Investigators.</article-title>
            <source>Circulation</source>
            <year>1992</year>
            <month>Jun</month>
            <volume>85</volume>
            <issue>6</issue>
            <fpage>2065</fpage>
            <page-range>2065-72</page-range>
            <pub-id pub-id-type="pmid">1591825</pub-id>
          </element-citation>
        </ref>
        <ref id="article-38287.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lewington</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Clarke</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Qizilbash</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Peto</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Collins</surname>
                <given-names>R</given-names>
              </name>
              <collab>Prospective Studies Collaboration</collab>
            </person-group>
            <article-title>Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies.</article-title>
            <source>Lancet</source>
            <year>2002</year>
            <month>Dec</month>
            <day>14</day>
            <volume>360</volume>
            <issue>9349</issue>
            <fpage>1903</fpage>
            <page-range>1903-13</page-range>
            <pub-id pub-id-type="pmid">12493255</pub-id>
          </element-citation>
        </ref>
        <ref id="article-38287.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stamler</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Stamler</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Neaton</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Wentworth</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Daviglus</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Garside</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Dyer</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Greenland</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Low risk-factor profile and long-term cardiovascular and noncardiovascular mortality and life expectancy: findings for 5 large cohorts of young adult and middle-aged men and women.</article-title>
            <source>JAMA</source>
            <year>1999</year>
            <month>Dec</month>
            <day>01</day>
            <volume>282</volume>
            <issue>21</issue>
            <fpage>2012</fpage>
            <page-range>2012-8</page-range>
            <pub-id pub-id-type="pmid">10591383</pub-id>
          </element-citation>
        </ref>
        <ref id="article-38287.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fern&#x000e1;ndez-Friera</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Fuster</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>L&#x000f3;pez-Melgar</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Oliva</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Garc&#x000ed;a-Ruiz</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Mendiguren</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bueno</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Pocock</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ib&#x000e1;&#x000f1;ez</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Fern&#x000e1;ndez-Ortiz</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sanz</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Normal LDL-Cholesterol Levels Are Associated With Subclinical Atherosclerosis in the Absence of Risk&#x000a0;Factors.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2017</year>
            <month>Dec</month>
            <day>19</day>
            <volume>70</volume>
            <issue>24</issue>
            <fpage>2979</fpage>
            <page-range>2979-2991</page-range>
            <pub-id pub-id-type="pmid">29241485</pub-id>
          </element-citation>
        </ref>
        <ref id="article-38287.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <collab>National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)</collab>
            <article-title>Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.</article-title>
            <source>Circulation</source>
            <year>2002</year>
            <month>Dec</month>
            <day>17</day>
            <volume>106</volume>
            <issue>25</issue>
            <fpage>3143</fpage>
            <page-range>3143-421</page-range>
            <pub-id pub-id-type="pmid">12485966</pub-id>
          </element-citation>
        </ref>
        <ref id="article-38287.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Haffner</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Lehto</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>R&#x000f6;nnemaa</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Py&#x000f6;r&#x000e4;l&#x000e4;</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Laakso</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction.</article-title>
            <source>N Engl J Med</source>
            <year>1998</year>
            <month>Jul</month>
            <day>23</day>
            <volume>339</volume>
            <issue>4</issue>
            <fpage>229</fpage>
            <page-range>229-34</page-range>
            <pub-id pub-id-type="pmid">9673301</pub-id>
          </element-citation>
        </ref>
        <ref id="article-38287.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <collab>Chronic Kidney Disease Prognosis Consortium</collab>
              <name>
                <surname>Matsushita</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>van der Velde</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Astor</surname>
                <given-names>BC</given-names>
              </name>
              <name>
                <surname>Woodward</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Levey</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>de Jong</surname>
                <given-names>PE</given-names>
              </name>
              <name>
                <surname>Coresh</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Gansevoort</surname>
                <given-names>RT</given-names>
              </name>
            </person-group>
            <article-title>Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis.</article-title>
            <source>Lancet</source>
            <year>2010</year>
            <month>Jun</month>
            <day>12</day>
            <volume>375</volume>
            <issue>9731</issue>
            <fpage>2073</fpage>
            <page-range>2073-81</page-range>
            <pub-id pub-id-type="pmid">20483451</pub-id>
          </element-citation>
        </ref>
        <ref id="article-38287.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wilhelmsson</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Vedin</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Elmfeldt</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Tibblin</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Wilhelmsen</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Smoking and myocardial infarction.</article-title>
            <source>Lancet</source>
            <year>1975</year>
            <month>Feb</month>
            <day>22</day>
            <volume>1</volume>
            <issue>7904</issue>
            <fpage>415</fpage>
            <page-range>415-20</page-range>
            <pub-id pub-id-type="pmid">48609</pub-id>
          </element-citation>
        </ref>
        <ref id="article-38287.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sun</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Bernstein</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Schulze</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Manson</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Stampfer</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Willett</surname>
                <given-names>WC</given-names>
              </name>
              <name>
                <surname>Hu</surname>
                <given-names>FB</given-names>
              </name>
            </person-group>
            <article-title>Red meat consumption and mortality: results from 2 prospective cohort studies.</article-title>
            <source>Arch Intern Med</source>
            <year>2012</year>
            <month>Apr</month>
            <day>09</day>
            <volume>172</volume>
            <issue>7</issue>
            <fpage>555</fpage>
            <page-range>555-63</page-range>
            <pub-id pub-id-type="pmid">22412075</pub-id>
          </element-citation>
        </ref>
        <ref id="article-38287.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Twig</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Yaniv</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Levine</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Leiba</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Goldberger</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Derazne</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Ben-Ami Shor</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Tzur</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Afek</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Shamiss</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Haklai</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Kark</surname>
                <given-names>JD</given-names>
              </name>
            </person-group>
            <article-title>Body-Mass Index in 2.3 Million Adolescents and Cardiovascular Death in Adulthood.</article-title>
            <source>N Engl J Med</source>
            <year>2016</year>
            <month>Jun</month>
            <day>23</day>
            <volume>374</volume>
            <issue>25</issue>
            <fpage>2430</fpage>
            <page-range>2430-40</page-range>
            <pub-id pub-id-type="pmid">27074389</pub-id>
          </element-citation>
        </ref>
        <ref id="article-38287.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fleisher</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Fleischmann</surname>
                <given-names>KE</given-names>
              </name>
              <name>
                <surname>Auerbach</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>Barnason</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Beckman</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Bozkurt</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Davila-Roman</surname>
                <given-names>VG</given-names>
              </name>
              <name>
                <surname>Gerhard-Herman</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Holly</surname>
                <given-names>TA</given-names>
              </name>
              <name>
                <surname>Kane</surname>
                <given-names>GC</given-names>
              </name>
              <name>
                <surname>Marine</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Nelson</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Spencer</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Thompson</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ting</surname>
                <given-names>HH</given-names>
              </name>
              <name>
                <surname>Uretsky</surname>
                <given-names>BF</given-names>
              </name>
              <name>
                <surname>Wijeysundera</surname>
                <given-names>DN</given-names>
              </name>
              <collab>American College of Cardiology</collab>
              <collab>American Heart Association</collab>
            </person-group>
            <article-title>2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2014</year>
            <month>Dec</month>
            <day>09</day>
            <volume>64</volume>
            <issue>22</issue>
            <fpage>e77</fpage>
            <page-range>e77-137</page-range>
            <pub-id pub-id-type="pmid">25091544</pub-id>
          </element-citation>
        </ref>
        <ref id="article-38287.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fleisher</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Fleischmann</surname>
                <given-names>KE</given-names>
              </name>
              <name>
                <surname>Auerbach</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>Barnason</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Beckman</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Bozkurt</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Davila-Roman</surname>
                <given-names>VG</given-names>
              </name>
              <name>
                <surname>Gerhard-Herman</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Holly</surname>
                <given-names>TA</given-names>
              </name>
              <name>
                <surname>Kane</surname>
                <given-names>GC</given-names>
              </name>
              <name>
                <surname>Marine</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Nelson</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Spencer</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Thompson</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ting</surname>
                <given-names>HH</given-names>
              </name>
              <name>
                <surname>Uretsky</surname>
                <given-names>BF</given-names>
              </name>
              <name>
                <surname>Wijeysundera</surname>
                <given-names>DN</given-names>
              </name>
            </person-group>
            <article-title>2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.</article-title>
            <source>Circulation</source>
            <year>2014</year>
            <month>Dec</month>
            <day>09</day>
            <volume>130</volume>
            <issue>24</issue>
            <fpage>2215</fpage>
            <page-range>2215-45</page-range>
            <pub-id pub-id-type="pmid">25085962</pub-id>
          </element-citation>
        </ref>
        <ref id="article-38287.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Devereaux</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Goldman</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Cook</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Gilbert</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Leslie</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Guyatt</surname>
                <given-names>GH</given-names>
              </name>
            </person-group>
            <article-title>Perioperative cardiac events in patients undergoing noncardiac surgery: a review of the magnitude of the problem, the pathophysiology of the events and methods to estimate and communicate risk.</article-title>
            <source>CMAJ</source>
            <year>2005</year>
            <month>Sep</month>
            <day>13</day>
            <volume>173</volume>
            <issue>6</issue>
            <fpage>627</fpage>
            <page-range>627-34</page-range>
            <pub-id pub-id-type="pmid">16157727</pub-id>
          </element-citation>
        </ref>
        <ref id="article-38287.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lee</surname>
                <given-names>TH</given-names>
              </name>
              <name>
                <surname>Marcantonio</surname>
                <given-names>ER</given-names>
              </name>
              <name>
                <surname>Mangione</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Thomas</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Polanczyk</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Cook</surname>
                <given-names>EF</given-names>
              </name>
              <name>
                <surname>Sugarbaker</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Donaldson</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Poss</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Ho</surname>
                <given-names>KK</given-names>
              </name>
              <name>
                <surname>Ludwig</surname>
                <given-names>LE</given-names>
              </name>
              <name>
                <surname>Pedan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Goldman</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery.</article-title>
            <source>Circulation</source>
            <year>1999</year>
            <month>Sep</month>
            <day>07</day>
            <volume>100</volume>
            <issue>10</issue>
            <fpage>1043</fpage>
            <page-range>1043-9</page-range>
            <pub-id pub-id-type="pmid">10477528</pub-id>
          </element-citation>
        </ref>
        <ref id="article-38287.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mozaffarian</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Benjamin</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Go</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Arnett</surname>
                <given-names>DK</given-names>
              </name>
              <name>
                <surname>Blaha</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Cushman</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>de Ferranti</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Despr&#x000e9;s</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Fullerton</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Howard</surname>
                <given-names>VJ</given-names>
              </name>
              <name>
                <surname>Huffman</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Judd</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Kissela</surname>
                <given-names>BM</given-names>
              </name>
              <name>
                <surname>Lackland</surname>
                <given-names>DT</given-names>
              </name>
              <name>
                <surname>Lichtman</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Lisabeth</surname>
                <given-names>LD</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mackey</surname>
                <given-names>RH</given-names>
              </name>
              <name>
                <surname>Matchar</surname>
                <given-names>DB</given-names>
              </name>
              <name>
                <surname>McGuire</surname>
                <given-names>DK</given-names>
              </name>
              <name>
                <surname>Mohler</surname>
                <given-names>ER</given-names>
              </name>
              <name>
                <surname>Moy</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Muntner</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Mussolino</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Nasir</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Neumar</surname>
                <given-names>RW</given-names>
              </name>
              <name>
                <surname>Nichol</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Palaniappan</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Pandey</surname>
                <given-names>DK</given-names>
              </name>
              <name>
                <surname>Reeves</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Rodriguez</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Sorlie</surname>
                <given-names>PD</given-names>
              </name>
              <name>
                <surname>Stein</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Towfighi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Turan</surname>
                <given-names>TN</given-names>
              </name>
              <name>
                <surname>Virani</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Willey</surname>
                <given-names>JZ</given-names>
              </name>
              <name>
                <surname>Woo</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Yeh</surname>
                <given-names>RW</given-names>
              </name>
              <name>
                <surname>Turner</surname>
                <given-names>MB</given-names>
              </name>
              <collab>American Heart Association Statistics Committee and Stroke Statistics Subcommittee</collab>
            </person-group>
            <article-title>Heart disease and stroke statistics--2015 update: a report from the American Heart Association.</article-title>
            <source>Circulation</source>
            <year>2015</year>
            <month>Jan</month>
            <day>27</day>
            <volume>131</volume>
            <issue>4</issue>
            <fpage>e29</fpage>
            <page-range>e29-322</page-range>
            <pub-id pub-id-type="pmid">25520374</pub-id>
          </element-citation>
        </ref>
        <ref id="article-38287.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Patel</surname>
                <given-names>AY</given-names>
              </name>
              <name>
                <surname>Eagle</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Vaishnava</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Cardiac risk of noncardiac surgery.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2015</year>
            <month>Nov</month>
            <day>10</day>
            <volume>66</volume>
            <issue>19</issue>
            <fpage>2140</fpage>
            <page-range>2140-2148</page-range>
            <pub-id pub-id-type="pmid">26541926</pub-id>
          </element-citation>
        </ref>
        <ref id="article-38287.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ramakrishna</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Sprung</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Ravi</surname>
                <given-names>BS</given-names>
              </name>
              <name>
                <surname>Chandrasekaran</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>McGoon</surname>
                <given-names>MD</given-names>
              </name>
            </person-group>
            <article-title>Impact of pulmonary hypertension on the outcomes of noncardiac surgery: predictors of perioperative morbidity and mortality.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2005</year>
            <month>May</month>
            <day>17</day>
            <volume>45</volume>
            <issue>10</issue>
            <fpage>1691</fpage>
            <page-range>1691-9</page-range>
            <pub-id pub-id-type="pmid">15893189</pub-id>
          </element-citation>
        </ref>
        <ref id="article-38287.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Goldman</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Caldera</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Nussbaum</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Southwick</surname>
                <given-names>FS</given-names>
              </name>
              <name>
                <surname>Krogstad</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Murray</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Burke</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>O'Malley</surname>
                <given-names>TA</given-names>
              </name>
              <name>
                <surname>Goroll</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>Caplan</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Nolan</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Carabello</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Slater</surname>
                <given-names>EE</given-names>
              </name>
            </person-group>
            <article-title>Multifactorial index of cardiac risk in noncardiac surgical procedures.</article-title>
            <source>N Engl J Med</source>
            <year>1977</year>
            <month>Oct</month>
            <day>20</day>
            <volume>297</volume>
            <issue>16</issue>
            <fpage>845</fpage>
            <page-range>845-50</page-range>
            <pub-id pub-id-type="pmid">904659</pub-id>
          </element-citation>
        </ref>
        <ref id="article-38287.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>L'Italien</surname>
                <given-names>GJ</given-names>
              </name>
              <name>
                <surname>Paul</surname>
                <given-names>SD</given-names>
              </name>
              <name>
                <surname>Hendel</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Leppo</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Cohen</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Fleisher</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Brown</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Zarich</surname>
                <given-names>SW</given-names>
              </name>
              <name>
                <surname>Cambria</surname>
                <given-names>RP</given-names>
              </name>
              <name>
                <surname>Cutler</surname>
                <given-names>BS</given-names>
              </name>
              <name>
                <surname>Eagle</surname>
                <given-names>KA</given-names>
              </name>
            </person-group>
            <article-title>Development and validation of a Bayesian model for perioperative cardiac risk assessment in a cohort of 1,081 vascular surgical candidates.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>1996</year>
            <month>Mar</month>
            <day>15</day>
            <volume>27</volume>
            <issue>4</issue>
            <fpage>779</fpage>
            <page-range>779-86</page-range>
            <pub-id pub-id-type="pmid">8613603</pub-id>
          </element-citation>
        </ref>
        <ref id="article-38287.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sprung</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Abdelmalak</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Gottlieb</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mayhew</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Hammel</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Levy</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>O'Hara</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Hertzer</surname>
                <given-names>NR</given-names>
              </name>
            </person-group>
            <article-title>Analysis of risk factors for myocardial infarction and cardiac mortality after major vascular surgery.</article-title>
            <source>Anesthesiology</source>
            <year>2000</year>
            <month>Jul</month>
            <volume>93</volume>
            <issue>1</issue>
            <fpage>129</fpage>
            <page-range>129-40</page-range>
            <pub-id pub-id-type="pmid">10861156</pub-id>
          </element-citation>
        </ref>
        <ref id="article-38287.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McFalls</surname>
                <given-names>EO</given-names>
              </name>
              <name>
                <surname>Ward</surname>
                <given-names>HB</given-names>
              </name>
              <name>
                <surname>Moritz</surname>
                <given-names>TE</given-names>
              </name>
              <name>
                <surname>Goldman</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Krupski</surname>
                <given-names>WC</given-names>
              </name>
              <name>
                <surname>Littooy</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Pierpont</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Santilli</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Rapp</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Hattler</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Shunk</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Jaenicke</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Thottapurathu</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Ellis</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Reda</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Henderson</surname>
                <given-names>WG</given-names>
              </name>
            </person-group>
            <article-title>Coronary-artery revascularization before elective major vascular surgery.</article-title>
            <source>N Engl J Med</source>
            <year>2004</year>
            <month>Dec</month>
            <day>30</day>
            <volume>351</volume>
            <issue>27</issue>
            <fpage>2795</fpage>
            <page-range>2795-804</page-range>
            <pub-id pub-id-type="pmid">15625331</pub-id>
          </element-citation>
        </ref>
        <ref id="article-38287.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mangano</surname>
                <given-names>DT</given-names>
              </name>
              <name>
                <surname>Layug</surname>
                <given-names>EL</given-names>
              </name>
              <name>
                <surname>Wallace</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Tateo</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group.</article-title>
            <source>N Engl J Med</source>
            <year>1996</year>
            <month>Dec</month>
            <day>05</day>
            <volume>335</volume>
            <issue>23</issue>
            <fpage>1713</fpage>
            <page-range>1713-20</page-range>
            <pub-id pub-id-type="pmid">8929262</pub-id>
          </element-citation>
        </ref>
        <ref id="article-38287.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Poldermans</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Boersma</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Bax</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Thomson</surname>
                <given-names>IR</given-names>
              </name>
              <name>
                <surname>van de Ven</surname>
                <given-names>LL</given-names>
              </name>
              <name>
                <surname>Blankensteijn</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Baars</surname>
                <given-names>HF</given-names>
              </name>
              <name>
                <surname>Yo</surname>
                <given-names>TI</given-names>
              </name>
              <name>
                <surname>Trocino</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Vigna</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Roelandt</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>van Urk</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group.</article-title>
            <source>N Engl J Med</source>
            <year>1999</year>
            <month>Dec</month>
            <day>09</day>
            <volume>341</volume>
            <issue>24</issue>
            <fpage>1789</fpage>
            <page-range>1789-94</page-range>
            <pub-id pub-id-type="pmid">10588963</pub-id>
          </element-citation>
        </ref>
        <ref id="article-38287.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <collab>POISE Study Group</collab>
              <name>
                <surname>Devereaux</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Yusuf</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Guyatt</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Leslie</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Villar</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Xavier</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Chrolavicius</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Greenspan</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Pogue</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Pais</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Xu</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>M&#x000e1;laga</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Avezum</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Chan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Montori</surname>
                <given-names>VM</given-names>
              </name>
              <name>
                <surname>Jacka</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Choi</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial.</article-title>
            <source>Lancet</source>
            <year>2008</year>
            <month>May</month>
            <day>31</day>
            <volume>371</volume>
            <issue>9627</issue>
            <fpage>1839</fpage>
            <page-range>1839-47</page-range>
            <pub-id pub-id-type="pmid">18479744</pub-id>
          </element-citation>
        </ref>
        <ref id="article-38287.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schouten</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Boersma</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Hoeks</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Benner</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>van Urk</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>van Sambeek</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Verhagen</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Khan</surname>
                <given-names>NA</given-names>
              </name>
              <name>
                <surname>Dunkelgrun</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bax</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Poldermans</surname>
                <given-names>D</given-names>
              </name>
              <collab>Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group</collab>
            </person-group>
            <article-title>Fluvastatin and perioperative events in patients undergoing vascular surgery.</article-title>
            <source>N Engl J Med</source>
            <year>2009</year>
            <month>Sep</month>
            <day>03</day>
            <volume>361</volume>
            <issue>10</issue>
            <fpage>980</fpage>
            <page-range>980-9</page-range>
            <pub-id pub-id-type="pmid">19726772</pub-id>
          </element-citation>
        </ref>
        <ref id="article-38287.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dunkelgrun</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Boersma</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Schouten</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Koopman-van Gemert</surname>
                <given-names>AW</given-names>
              </name>
              <name>
                <surname>van Poorten</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Bax</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Thomson</surname>
                <given-names>IR</given-names>
              </name>
              <name>
                <surname>Poldermans</surname>
                <given-names>D</given-names>
              </name>
              <collab>Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group</collab>
            </person-group>
            <article-title>Bisoprolol and fluvastatin for the reduction of perioperative cardiac mortality and myocardial infarction in intermediate-risk patients undergoing noncardiovascular surgery: a randomized controlled trial (DECREASE-IV).</article-title>
            <source>Ann Surg</source>
            <year>2009</year>
            <month>Jun</month>
            <volume>249</volume>
            <issue>6</issue>
            <fpage>921</fpage>
            <page-range>921-6</page-range>
            <pub-id pub-id-type="pmid">19474688</pub-id>
          </element-citation>
        </ref>
        <ref id="article-38287.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bouri</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Shun-Shin</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Cole</surname>
                <given-names>GD</given-names>
              </name>
              <name>
                <surname>Mayet</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Francis</surname>
                <given-names>DP</given-names>
              </name>
            </person-group>
            <article-title>Meta-analysis of secure randomised controlled trials of &#x003b2;-blockade to prevent perioperative death in non-cardiac surgery.</article-title>
            <source>Heart</source>
            <year>2014</year>
            <month>Mar</month>
            <volume>100</volume>
            <issue>6</issue>
            <fpage>456</fpage>
            <page-range>456-64</page-range>
            <pub-id pub-id-type="pmid">23904357</pub-id>
          </element-citation>
        </ref>
        <ref id="article-38287.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Durazzo</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Machado</surname>
                <given-names>FS</given-names>
              </name>
              <name>
                <surname>Ikeoka</surname>
                <given-names>DT</given-names>
              </name>
              <name>
                <surname>De Bernoche</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Monachini</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Puech-Le&#x000e3;o</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Caramelli</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomized trial.</article-title>
            <source>J Vasc Surg</source>
            <year>2004</year>
            <month>May</month>
            <volume>39</volume>
            <issue>5</issue>
            <fpage>967</fpage>
            <page-range>967-75; discussion 975-6</page-range>
            <pub-id pub-id-type="pmid">15111846</pub-id>
          </element-citation>
        </ref>
        <ref id="article-38287.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lindenauer</surname>
                <given-names>PK</given-names>
              </name>
              <name>
                <surname>Pekow</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Gutierrez</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Benjamin</surname>
                <given-names>EM</given-names>
              </name>
            </person-group>
            <article-title>Lipid-lowering therapy and in-hospital mortality following major noncardiac surgery.</article-title>
            <source>JAMA</source>
            <year>2004</year>
            <month>May</month>
            <day>05</day>
            <volume>291</volume>
            <issue>17</issue>
            <fpage>2092</fpage>
            <page-range>2092-9</page-range>
            <pub-id pub-id-type="pmid">15126437</pub-id>
          </element-citation>
        </ref>
        <ref id="article-38287.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Devereaux</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Sessler</surname>
                <given-names>DI</given-names>
              </name>
              <name>
                <surname>Leslie</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kurz</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mrkobrada</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Alonso-Coello</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Villar</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Sigamani</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Biccard</surname>
                <given-names>BM</given-names>
              </name>
              <name>
                <surname>Meyhoff</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Parlow</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Guyatt</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Robinson</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Garg</surname>
                <given-names>AX</given-names>
              </name>
              <name>
                <surname>Rodseth</surname>
                <given-names>RN</given-names>
              </name>
              <name>
                <surname>Botto</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Lurati Buse</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Xavier</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Chan</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Tiboni</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Cook</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Kumar</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Forget</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Malaga</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Fleischmann</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Amir</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Eikelboom</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mizera</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Torres</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>CY</given-names>
              </name>
              <name>
                <surname>Vanhelder</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Paniagua</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Berwanger</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Srinathan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Graham</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Pasin</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Le Manach</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Gao</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Pogue</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Whitlock</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Lamy</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kearon</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Chow</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Pettit</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Chrolavicius</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Yusuf</surname>
                <given-names>S</given-names>
              </name>
              <collab>POISE-2 Investigators</collab>
            </person-group>
            <article-title>Clonidine in patients undergoing noncardiac surgery.</article-title>
            <source>N Engl J Med</source>
            <year>2014</year>
            <month>Apr</month>
            <day>17</day>
            <volume>370</volume>
            <issue>16</issue>
            <fpage>1504</fpage>
            <page-range>1504-13</page-range>
            <pub-id pub-id-type="pmid">24679061</pub-id>
          </element-citation>
        </ref>
        <ref id="article-38287.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Devereaux</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Mrkobrada</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sessler</surname>
                <given-names>DI</given-names>
              </name>
              <name>
                <surname>Leslie</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Alonso-Coello</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Kurz</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Villar</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Sigamani</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Biccard</surname>
                <given-names>BM</given-names>
              </name>
              <name>
                <surname>Meyhoff</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Parlow</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Guyatt</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Robinson</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Garg</surname>
                <given-names>AX</given-names>
              </name>
              <name>
                <surname>Rodseth</surname>
                <given-names>RN</given-names>
              </name>
              <name>
                <surname>Botto</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Lurati Buse</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Xavier</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Chan</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Tiboni</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Cook</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Kumar</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Forget</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Malaga</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Fleischmann</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Amir</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Eikelboom</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mizera</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Torres</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>CY</given-names>
              </name>
              <name>
                <surname>VanHelder</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Paniagua</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Berwanger</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Srinathan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Graham</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Pasin</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Le Manach</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Gao</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Pogue</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Whitlock</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Lamy</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kearon</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Baigent</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Chow</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Pettit</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Chrolavicius</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Yusuf</surname>
                <given-names>S</given-names>
              </name>
              <collab>POISE-2 Investigators</collab>
            </person-group>
            <article-title>Aspirin in patients undergoing noncardiac surgery.</article-title>
            <source>N Engl J Med</source>
            <year>2014</year>
            <month>Apr</month>
            <day>17</day>
            <volume>370</volume>
            <issue>16</issue>
            <fpage>1494</fpage>
            <page-range>1494-503</page-range>
            <pub-id pub-id-type="pmid">24679062</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
